Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells

This publication has 24 references indexed in Scilit:

• Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial
  JNCI Journal of the National Cancer Institute, 1993
• Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2
  Biochemical and Biophysical Research Communications, 1993
• Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostates
  The Prostate, 1993
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
  Nature, 1991
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990
• Synergistic Activity of Suramin With Tumor Necrosis Factor and Doxorubicin on Human Prostate Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1990
• Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A
  FEBS Letters, 1989
• Activation of a Ca²⁺−Mg²⁺‐dependent endonuclease as an early event in castration‐induced prostatic cell death
  The Prostate, 1988
• Role of iron in the proliferation of the established human tumor cell lines U‐937 and K‐562: Effects of suramin and a lipophilic iron chelator (PIH)
  Scandinavian Journal of Haematology, 1986
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976